Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Vioxx Detailing Should Have Addressed VIGOR Risks – FDA’s Jenkins

This article was originally published in The Tan Sheet

Executive Summary

Merck should have included risk findings from the VIGOR study when promoting Vioxx to physicians before the data was added to labeling, FDA Office of New Drugs Director John Jenkins told a congressional hearing May 5

You may also be interested in...



Opportunity Knocks For Supplements Pitched As Problem Solvers

Dietary supplement firms, even working within the limits of FDA's claims regulations, can capitalize on more opportunities to promote their products as problem solvers, according to market consultants

Opportunity Knocks For Supplements Pitched As Problem Solvers

Dietary supplement firms, even working within the limits of FDA's claims regulations, can capitalize on more opportunities to promote their products as problem solvers, according to market consultants

Opportunity Knocks For Supplements Pitched As Problem Solvers

Dietary supplement firms, even working within the limits of FDA's claims regulations, can capitalize on more opportunities to promote their products as problem solvers, according to market consultants

Related Content

Topics

UsernamePublicRestriction

Register

PS098173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel